For Quick Alerts
For Daily Alerts
IFC sells its shareholding in Dabur Pharma
New Delhi, Aug 18 (UNI) Dabur Pharma Ltd today announced that International Finance Corporation (IFC), a private sector lending arm of the World Bank Group, has sold its entire stake of 12.14 million shares in the firm.
The company last week said its board had approved execution of a letter of intent (LoI) for an alliance with Fresenius Kabi AG, a unit of German health Care group Fresenius SE, for jointly developing business and providing global market access to Dabur's products.
Fresenius Kabi, which provides infusion therapy such as intra-venous drugs and clinical nutrition, said it will invest 30 million euros in the active pharmaceutical ingredient (API) plant of the company.
UNI
SBA
SP
DS1301
Comments
Story first published: Monday, August 18, 2008, 13:33 [IST]